Video

VIDEO: Surgery succeeds with select hidradenitis suppurativa patients


 


WASHINGTON– Medication has its limits for some patients with more severe hidradenitis suppurativa, and these patients can often benefit from surgical treatment, Chris Sayed, MD, said at an educational session held by George Washington University.

The video associated with this article is no longer available on this site. Please view all of our videos on the MDedge YouTube channel.

“Especially if patients have relatively limited areas of sinus, being able to do some local procedures [is] what will get the patient a lot better,” Dr. Sayed of the department of dermatology at the University of North Carolina, Chapel Hill, said in a video interview. “Whereas the medicines would never have made that sinus go away.”

The meeting was supported by AbbVie. Dr. Sayed disclosed financial relationships with the company.

Recommended Reading

NORD and Neurology Reviews Publish Special Report
MDedge Dermatology
Save the Date for the 2017 NORD Summit
MDedge Dermatology
Film Festival Devoted to Rare Diseases Scheduled for October
MDedge Dermatology
Applications Are Being Accepted for Free Family Rare Disease Summer Camp
MDedge Dermatology
Largest-Ever Study of Pemphigus and Pemphigoid Launched
MDedge Dermatology
Pamela Gavin of NORD to Speak at Technology and Rare Neurological Diseases Symposium
MDedge Dermatology
Foundation for Prader-Willi Research Promotes Awareness of Guidelines Related to Use of Human Growth Hormone
MDedge Dermatology
New diagnostic tool identifies severe ADAMTS13 deficiency
MDedge Dermatology
Infliximab safe for recently vaccinated Kawasaki patients
MDedge Dermatology
DTC genetic health risk tests: Beware
MDedge Dermatology